View Older Stories View More Recent Stories

May 6, 2020 04:05PM GBT Reports Recent Business Progress and First Quarter 2020 Financial Results
Apr 29, 2020 08:00AM GBT to Announce First Quarter 2020 Financial Results on Wednesday, May 6, 2020
Apr 3, 2020 08:00AM GBT Announces New Employment Inducement Grants
Apr 2, 2020 01:00PM GBT Commits $250,000 to Support the Sickle Cell Disease Community During COVID-19 Pandemic
Mar 17, 2020 08:00AM GBT Takes Steps to Support Public Health Efforts to Address COVID-19 Pandemic
Mar 4, 2020 08:00AM GBT Announces New Employment Inducement Grants
Feb 26, 2020 04:05PM GBT Reports Recent Business Progress and Fourth Quarter and Full Year 2019 Financial Results
Feb 25, 2020 08:00AM GBT Announces Participation at the Cowen and Company 40th Annual Healthcare Conference
Feb 20, 2020 08:00AM GBT Accepting Proposals for 2020 ACCEL Grants to Support Novel Access-to-Care Programs for People Living with Sickle Cell Disease
Feb 19, 2020 08:00AM GBT to Announce Fourth Quarter and Full Year 2019 Financial Results on Wednesday, February 26, 2020
Feb 3, 2020 08:00AM GBT Announces New Employment Inducement Grants
Feb 3, 2020 08:00AM GBT Announces New Employment Inducement Grants
Jan 8, 2020 08:00AM GBT Announces New Employment Inducement Grants
Jan 7, 2020 08:00AM GBT to Present at the 38th Annual J.P. Morgan Healthcare Conference
Dec 18, 2019 08:57AM Global Blood Therapeutics (GBT) Secures $150 Million Non-Dilutive Term Loan Financing
Dec 18, 2019 07:15AM GBT Secures $150 Million Non-Dilutive Term Loan Financing
Dec 18, 2019 07:02AM Global Blood Therapeutics (GBT) and Syros Partner (SYRS) to Discover, Develop and Commercialize Novel Therapies for SCD and Beta Thalassemia
Dec 18, 2019 07:00AM GBT and Syros Partner to Discover, Develop and Commercialize Novel Therapies for Sickle Cell Disease and Beta Thalassemia
Dec 4, 2019 08:00AM GBT Announces New Employment Inducement Grants
Nov 26, 2019 08:00AM GBT Announces Participation at Upcoming Investor Conferences in December
Nov 25, 2019 04:13PM Global Blood Therapeutics (GBT) Confirms FDA Approves Oxbryta for SCD
Nov 25, 2019 04:03PM FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease
Nov 25, 2019 04:03PM FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease
Nov 7, 2019 04:05PM GBT Reports Recent Business Progress and Third Quarter 2019 Financial Results
Nov 6, 2019 09:09AM Global Blood Therapeutics (GBT) Announces Upcoming Data Presentations at ASH
Nov 6, 2019 09:00AM GBT Announces Upcoming Data Presentations at 61st American Society of Hematology Annual Meeting & Exposition
Nov 4, 2019 08:00AM GBT Announces New Employment Inducement Grants
Oct 21, 2019 08:10AM GBT (GBT) Announces Results of Post-hoc Analysis of Phase 3 HOPE Study Showing Improvement in Leg Ulcers in Patients with SCD Treated with Voxelotor
Oct 21, 2019 08:00AM GBT Announces Results of Post-hoc Analysis of Phase 3 HOPE Study Showing Improvement in Leg Ulcers in Patients with Sickle Cell Disease Treated with Voxelotor
Oct 7, 2019 08:00AM GBT Announces New Employment Inducement Grants
Oct 2, 2019 08:00AM GBT Announces Upcoming Presentations at the 47th Annual National Sickle Cell Disease Association of America (SCDAA) Convention
Oct 1, 2019 08:00AM GBT to Host Analyst & Investor Day on October 8 in New York
Sep 25, 2019 08:00AM GBT Announces Participation at the 2019 Cantor Global Healthcare Conference
Sep 5, 2019 08:07AM Global Blood Therapeutics (GBT) Announces FDA Acceptance of NDA and Priority Review for Voxelotor for Treatment of SCD
Sep 5, 2019 08:00AM GBT Announces U.S. Food and Drug Administration Acceptance of New Drug Application and Priority Review for Voxelotor for the Treatment of Sickle Cell Disease
Sep 4, 2019 08:00AM GBT Announces New Employment Inducement Grants
Sep 3, 2019 04:05PM GBT Announces Participation at the 2019 Morgan Stanley Global Healthcare Conference
Sep 3, 2019 08:00AM GBT and Sickle Cell Disease Association of America to Host 8th Annual Sickle Cell Disease (SCD) Therapeutics Conference
Aug 7, 2019 04:05PM GBT Reports Recent Business Progress and Second Quarter 2019 Financial Results
Aug 6, 2019 08:00AM GBT Announces Participation at the 2019 Wedbush PacGrow Healthcare Conference
Aug 2, 2019 08:00AM GBT Announces New Employment Inducement Grants
Jul 10, 2019 08:00AM GBT and Advocates Launch Disease Awareness Campaign Focused on Breaking Down Stigmas Associated with Sickle Cell Disease
Jul 9, 2019 08:00AM GBT Announces New Employment Inducement Grants
Jun 14, 2019 06:20AM GBT (GBT) Announces Updated 24-Week Efficacy Data from Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor
Jun 14, 2019 02:32AM GBT Announces Updated 24-Week Efficacy Data from All Patients Enrolled in Phase 3 HOPE Study Showing Statistically Significant and Sustained Improvements in Hemoglobin with Voxelotor
Jun 10, 2019 08:00AM GBT Awards More than $200,000 in Grants to Five Nonprofit Organizations through New ACCEL Program Aimed at Improving Access to Healthcare for People Living with Sickle Cell Disease
Jun 7, 2019 08:00AM GBT Announces New Employment Inducement Grants
May 16, 2019 09:05AM GBT Announces Upcoming Data Presentations at 24th European Hematology Association (EHA) Congress Supporting Voxelotor Sickle Cell Disease Program
May 8, 2019 04:05PM GBT Reports Recent Business Progress and First Quarter 2019 Financial Results
May 6, 2019 08:00AM GBT Announces New Employment Inducement Grants
View More Recent Stories View Older Stories